Esperion Therapeutics Inc (ESPR)
Equity Ratio
-66.58%
Quarterly · Period ending:
ESPR Equity Ratio
Latest reported-66.58%period ending
Latest reported-66.58%period ending
ESPR Quarterly Equity Ratio (82.28% → -66.58%)
Latest values, visible window
High-resolution chart · PNG
ESPR equity ratio history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Equity Ratio |
|---|---|
| -66.5755% | |
| -64.8152% | |
| -123.9935% | |
| -124.9% | |
| -131.5348% | |
| -113.0594% | |
| -117.8582% | |
| -97.7012% | |
| -78.8876% | |
| -221.0898% | |
| -185.2665% | |
| -158.5408% | |
| -130.9127% | |
| -130.5878% | |
| -94.0136% | |
| -95.9596% | |
| -72.6375% | |
| -51.6114% | |
| -161.019% | |
| -108.5035% | |
| -96.6935% | |
| -27.2135% | |
| 3.5702% | |
| 25.8782% | |
| -27.9701% | |
| 9.303% | |
| 26.839% | |
| 41.8809% | |
| 74.0056% | |
| 55.1533% | |
| 75.7025% | |
| 83.42% | |
| 87.6947% | |
| 88.0706% | |
| 88.8222% | |
| 83.1923% | |
| 89.6604% | |
| 93.2259% | |
| 96.3566% | |
| 96.574% | |
| 97.1067% | |
| 97.1875% | |
| 96.7649% | |
| 96.6761% | |
| 96.681% | |
| 93.1703% | |
| 82.9721% | |
| 85.0217% | |
| 95.4602% | |
| 94.6324% | |
| 96.1387% | |
| 65.9856% | |
| 88.6762% | |
| -237.8098% | |
| 85.5456% | |
| 62.0475% | |
| 71.3611% | |
| 75.3652% | |
| 78.9339% | |
| 80.507% | |
| 82.2916% | |
| 84.8838% | |
| 85.6337% | |
| 82.6025% | |
| 86.2258% | |
| 86.9204% | |
| 87.9091% | |
| 71.6157% | |
| 82.2768% |